Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00940862
What this trial is testing

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisVascular InflammationCoronary Atherosclerosis
Innovaderm Research Inc. 30
Large-scale testing (Phase 3)Study completedNCT00254982
What this trial is testing

Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 593
Not applicableUnknownNCT03986918
What this trial is testing

Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System

Who this might be right for
Joint DiseasesOsteoarthritis, HipRheumatoid Arthritis+2 more
Ortho Development Corporation 400
Post-approval studies (Phase 4)Looking for participantsNCT03827876
What this trial is testing

Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 30
Not applicableStudy completedNCT01316224
What this trial is testing

Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie (prior sponsor, Abbott) 52
Testing effectiveness (Phase 2)Study completedNCT03782792
What this trial is testing

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 53
Testing effectiveness (Phase 2)Study completedNCT03706209
What this trial is testing

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
MetrioPharm AG 155
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367
What this trial is testing

Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, Zhejiang University, School of Medicine 135
Not applicableStudy completedNCT00096928
What this trial is testing

Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Who this might be right for
Psoriasis
Genentech, Inc. 1,846
Not applicableStudy completedNCT06691763
What this trial is testing

Pythagorean Self-Awareness Intervention on Psoriasis Patients.

Who this might be right for
Psoriasis
National and Kapodistrian University of Athens 21
Early research (Phase 1)Study completedNCT05332704
What this trial is testing

Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

Who this might be right for
Plaque Psoriasis
Ono Pharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT01043393
What this trial is testing

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Not applicableStudy completedNCT03539419
What this trial is testing

Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain

Who this might be right for
Psoriasis
Amgen 153
Not applicableNot Yet RecruitingNCT06794671
What this trial is testing

A Basket Trial of Vunakizumab in Inflammatory Skin Diseases

Who this might be right for
Inflammatory Skin DiseasesPsoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 10,000
Not applicableStudy completedNCT03658252
What this trial is testing

Efficacy of Targeted Intervention for Topical Steroid Phobia.

Who this might be right for
Dermatologic DiseasePhobiaAdherence, Medication
National University Health System, Singapore 270
Testing effectiveness (Phase 2)Study completedNCT00368654
What this trial is testing

Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy

Who this might be right for
Psoriasis
University of California, Davis 12
Not applicableStudy completedNCT04402554
What this trial is testing

Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis
University Hospital, Clermont-Ferrand 501
Not applicableUnknownNCT06213688
What this trial is testing

Involvement of Pollutants in Atopic Dermatitis and Psoriasis

Who this might be right for
PsoriasisAtopic Dermatitis
Assistance Publique Hopitaux De Marseille 64
Large-scale testing (Phase 3)Study completedNCT03535194
What this trial is testing

Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,484
Not applicableStudy completedNCT00422617
What this trial is testing

Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients

Who this might be right for
Chronic Plaque Psoriasis
Uni-Pharma 40
Next Page